September 2020,
by Cormac Sheridan
© 2021 Adrenomed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung
Article in BioWorld: Adrecizumab shows apparent mortality benefit in septic shock trial
16. September 2020
Menu